Filing Flows › Traws Pharma (TRAW) › Q2 2025 › vs Q2 2024
Traws Pharma (TRAW) Q2 2025 vs Q2 2024 (year over year)
Traws Pharma's revenue rose $2.7M (48×) from $57K in Q2 2024 to $2.7M in Q2 2025.
Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart draws each line against Q2 2024, the increases inside each band.
Every line
| Line | Q2 2025 | Q2 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $2.7M | $57K | $2.7M | 48× |
| Other income, net | $334K | $205K | $129K | +63% |
| Net loss | $915K | $123M | −$122M | -99% |
| Costs & expenses | $4.0M | $123M | −$119M | -97% |
| Operating costs | $4.0M | $123M | −$119M | -97% |
| Research & development | $2.3M | $4.0M | −$1.7M | -42% |
| General & admin | $1.7M | $2.0M | −$286K | -14% |
| Operating cash sources | $6.1M | $10.2M | −$4.2M | -41% |
| Depreciation & amortization | $1K | $4K | −$3K | -75% |
| Share-based compensation | $105K | $380K | −$275K | -72% |
| Cash used in operations | $6.0M | $9.9M | −$3.9M | -39% |
| Net loss absorbed | $915K | $123M | −$122M | -99% |
| Working capital & other | $5.2M | −$113M | $118M | — |
Questions
How much did Traws Pharma's revenue grow year over year in Q2 2025?
Traws Pharma's revenue rose $2.7M (48×) from $57K in Q2 2024 to $2.7M in Q2 2025.